End-stage cardiomyopathy because of hereditary hemochromatosis successfully treated with erythrocytapheresis in combination with left ventricular assist device support.

E. Rombout-Sestrienkova; N. de Jonge; K. Martinakova; C. Klopping; K.P.M. van Galen; A. Vink; E.M. Wajon; W.M Smit; C. van Bree; G.H. Koek

doi:10.1161/CIRCHEARTFAILURE.114.001198

End-stage cardiomyopathy because of hereditary hemochromatosis successfully treated with erythrocytapheresis in combination with left ventricular assist device support.

E. Rombout-Sestrienkova
, N. de Jonge
, K. Martinakova
, C. Klopping
, K.P.M. van Galen
, A. Vink
, E.M. Wajon
, W.M Smit
, C. van Bree
, G.H. Koek

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	541-543
Number of pages	3
Journal	Circulation. Heart Failure
Volume	7
Issue number	3
DOIs	https://doi.org/10.1161/CIRCHEARTFAILURE.114.001198
Publication status	Published - 2014

Keywords

Cardiomyopathies
Combined Modality Therapy
Cytapheresis
Erythrocytes
Heart-Assist Devices
Hemochromatosis
Humans
Male
Middle Aged
Treatment Outcome
Ventricular Dysfunction, Left

Access to Document

10.1161/CIRCHEARTFAILURE.114.001198

Cite this

Rombout-Sestrienkova, E., de Jonge, N., Martinakova, K., Klopping, C., van Galen, K. P. M., Vink, A., Wajon, E. M., Smit, W. M., van Bree, C., & Koek, G. H. (2014). End-stage cardiomyopathy because of hereditary hemochromatosis successfully treated with erythrocytapheresis in combination with left ventricular assist device support. Circulation. Heart Failure, 7(3), 541-543. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001198

@article{b7a5ec535b37455e9d83a47b1033e0c0,

title = "End-stage cardiomyopathy because of hereditary hemochromatosis successfully treated with erythrocytapheresis in combination with left ventricular assist device support.",

keywords = "Cardiomyopathies, Combined Modality Therapy, Cytapheresis, Erythrocytes, Heart-Assist Devices, Hemochromatosis, Humans, Male, Middle Aged, Treatment Outcome, Ventricular Dysfunction, Left",

author = "E. Rombout-Sestrienkova and \{de Jonge\}, N. and K. Martinakova and C. Klopping and \{van Galen\}, K.P.M. and A. Vink and E.M. Wajon and W.M Smit and \{van Bree\}, C. and G.H. Koek",

year = "2014",

doi = "10.1161/CIRCHEARTFAILURE.114.001198",

language = "English",

volume = "7",

pages = "541--543",

journal = "Circulation. Heart Failure",

issn = "1941-3289",

publisher = "Lippincott Williams \& Wilkins",

number = "3",

}

Rombout-Sestrienkova, E, de Jonge, N, Martinakova, K, Klopping, C, van Galen, KPM, Vink, A, Wajon, EM, Smit, WM, van Bree, C & Koek, GH 2014, 'End-stage cardiomyopathy because of hereditary hemochromatosis successfully treated with erythrocytapheresis in combination with left ventricular assist device support.', Circulation. Heart Failure, vol. 7, no. 3, pp. 541-543. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001198

End-stage cardiomyopathy because of hereditary hemochromatosis successfully treated with erythrocytapheresis in combination with left ventricular assist device support. / Rombout-Sestrienkova, E.; de Jonge, N.; Martinakova, K. et al.
In: Circulation. Heart Failure, Vol. 7, No. 3, 2014, p. 541-543.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - End-stage cardiomyopathy because of hereditary hemochromatosis successfully treated with erythrocytapheresis in combination with left ventricular assist device support.

AU - Rombout-Sestrienkova, E.

AU - de Jonge, N.

AU - Martinakova, K.

AU - Klopping, C.

AU - van Galen, K.P.M.

AU - Vink, A.

AU - Wajon, E.M.

AU - Smit, W.M

AU - van Bree, C.

AU - Koek, G.H.

PY - 2014

Y1 - 2014

KW - Cardiomyopathies

KW - Combined Modality Therapy

KW - Cytapheresis

KW - Erythrocytes

KW - Heart-Assist Devices

KW - Hemochromatosis

KW - Humans

KW - Male

KW - Middle Aged

KW - Treatment Outcome

KW - Ventricular Dysfunction, Left

U2 - 10.1161/CIRCHEARTFAILURE.114.001198

DO - 10.1161/CIRCHEARTFAILURE.114.001198

M3 - Article

C2 - 24847131

SN - 1941-3289

VL - 7

SP - 541

EP - 543

JO - Circulation. Heart Failure

JF - Circulation. Heart Failure

IS - 3

ER -